Yahoo Web Search

Search results

1. Vertex Pharmaceuticals Incorporated

   NasdaqGS: VRTX

   441.13

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -5.75 (-1.29%)

   At close:4:00 PM EDTWed. May 29, 2024

   440.13 -1.00 (-0.23%)

   Pre mkt:7:26 AM EDTThu. May 30, 2024

   Nasdaq Real Time Price (USD) · Pre-Market Time

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	445.56
     High	448.21
     Low	440.56

   • Mkt Cap	113.83B
     P/E (TTM)	28.64
     Div & Yield	N/A & N/A

   • Prev. Close	446.88
     52 Wk. Low	320.01
     52 Wk. High	457.66

   More about VRTX

   What analysts are saying

   Morningstar Bearish Published May 07 · Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.... Read more

   Top stories

   • VRTX
     -1.29%

   Insider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

   Yahoo Finance · 5 days ago

   

   • VRTX
     -1.29%

   Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...

   Yahoo Finance · 1 week ago

   

   • VRTX
     -1.29%

   Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock

   Yahoo Finance · 2 weeks ago

   

   Related stocks

   • REGN
     Regeneron Pharmaceuticals, Inc.
     REGN
     966.49
     -0.69%
   • BIIB
     Biogen Inc.
     BIIB
     214.41
     -1.98%
   • INCY
     Incyte Corporation
     INCY
     56.92
     -0.58%
   • ILMN
     Illumina, Inc.
     ILMN
     101.76
     -3.11%
   • BMRN
     BioMarin Pharmaceutical Inc.
     BMRN
     75.06
     +0.85%

   More on Yahoo Finance

2. finance.yahoo.com › news › abbott-dexcom-investorsShould Abbott and DexCom Investors Be Worried About Vertex ...

   finance.yahoo.com › news › abbott-dexcom-investors

   • Cached

   11 hours ago · The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of May 28, 2024. Keith Speights has positions in Vertex ...

3. People also ask

   Should you buy VRTX (VRTX) stock?

   • The average analyst rating for VRTX stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP. Sources: Price targets and analyst ratings provided by Benzinga.

   Vertex Pharmaceuticals Incorporated (VRTX) Stock Forecast & Price

   stockanalysis.com/stocks/vrtx/forecast/

   See all results for this question

   Is Vertex Pharmaceuticals (VRTX) a great value stock right now?

   • Vertex Pharmaceuticals and Techne are sporting Zacks Ranks of #2 (Buy) and #4 (Sell), respectively, right now. This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that VRTX is likely seeing its earnings outlook improve to a greater extent.

   VRTX or TECH: Which Is the Better Value Stock Right Now?

   finance.yahoo.com/news/vrtx-tech-better-value-stock-164004982.html

   See all results for this question

   Is vxrt stock a good long-term investment?

   • Forecst.com predicts future values using technical analysis of a large number of analytical parameters. VXRT stock returns are also predicted based on historical data. According to our research, VXRT stock is a good long-term investment. VXRT share price has been in a bull cycle for the past year. Vaxart, Inc. stock trend is positive .

   VXRT stock forecast for 2023 – 2027 - FORECST.COM

   forecst.com/stock-forecast/vxrt/

   See all results for this question

   Is vrttx a good investment?

   • VRTTX is not currently ranked. The fund has returned 8.31 percent over the past year, 9.12 percent over the past three years, 10.17 percent over the past five years, and 10.44 percent over the past decade. Fees are Low compared to funds in the same category. Vanguard Russell 3000 Index Fund has an expense ratio of 0.08 percent.

   Vanguard Russell 3000 Index Fund (VRTTX) - U.S. News

   money.usnews.com/funds/mutual-funds/large-blend/vanguard-russell-3000-index-fund/vrttx

   See all results for this question

4. in.marketscreener.com › quote › stockVertex Pharmaceuticals Insider Sold Shares Worth $715,205 ...

   in.marketscreener.com › quote › stock

   • Cached

   15 hours ago · -- Reshma Kewalramani, Director, CEO & President, on May 24, 2024, sold 1,565 shares in Vertex Pharmaceuticals for $715,205. Following the Form 4 filing with the SEC, Kewalramani has control over a...

5. www.marketbeat.com › stocks › NASDAQ(RPTP) (RPTP) Stock Trends and Sentiment 2024 - MarketBeat

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   11 hours ago · Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.

6. www.stockwatch.com › News › ItemNot Logged In - stockwatch.com

   www.stockwatch.com › News › Item

   • Cached

   1 hour ago · Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, CBoe Canada, Montreal, Nasdaq, NYSE, Amex, OTC Markets and Cboe.

7. stock.10jqka.com.cn › 20240530 › c658342140福泰制药5月29日成交额为4.28亿美元 成交额较上个交易日减少30.73%。

   stock.10jqka.com.cn › 20240530 › c658342140

   • Cached

   11 hours ago · 2024年5月29日，生物科技公司福泰制药（vrtx）成交额为4.28亿美元，在当日美股中排第176名，成交额较昨日减少30.73%，当日成交量为96.75万。

8. en.wikipedia.org › wiki › Russell_1000_IndexRussell 1000 Index - Wikipedia

   en.wikipedia.org › wiki › Russell_1000_Index

   • Cached

   11 hours ago · The Russell 1000 Index is a stock market index that tracks the highest-ranking 1,000 stocks in the Russell 3000 Index, which represent about 93% of the total market capitalization of that index. As of 31 December 2023 [update] , the stocks of the Russell 1000 Index had a weighted average market capitalization of $666.0 billion and a median ...